IE48269B1 - A process for producing gefarnate-containing solid preparations - Google Patents

A process for producing gefarnate-containing solid preparations

Info

Publication number
IE48269B1
IE48269B1 IE725/79A IE72579A IE48269B1 IE 48269 B1 IE48269 B1 IE 48269B1 IE 725/79 A IE725/79 A IE 725/79A IE 72579 A IE72579 A IE 72579A IE 48269 B1 IE48269 B1 IE 48269B1
Authority
IE
Ireland
Prior art keywords
gefarnate
pka
carrier
adjusting agent
process according
Prior art date
Application number
IE725/79A
Other languages
English (en)
Other versions
IE790725L (en
Original Assignee
Angeli Inst Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Angeli Inst Spa filed Critical Angeli Inst Spa
Publication of IE790725L publication Critical patent/IE790725L/xx
Publication of IE48269B1 publication Critical patent/IE48269B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IE725/79A 1978-03-14 1979-08-08 A process for producing gefarnate-containing solid preparations IE48269B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP53029746A JPS6026093B2 (ja) 1978-03-14 1978-03-14 ゲフアルナート含有固型製剤の製造方法

Publications (2)

Publication Number Publication Date
IE790725L IE790725L (en) 1979-09-14
IE48269B1 true IE48269B1 (en) 1984-11-28

Family

ID=12284653

Family Applications (1)

Application Number Title Priority Date Filing Date
IE725/79A IE48269B1 (en) 1978-03-14 1979-08-08 A process for producing gefarnate-containing solid preparations

Country Status (17)

Country Link
JP (1) JPS6026093B2 (ja)
AR (1) AR218711A1 (ja)
BE (1) BE874795A (ja)
CH (1) CH637827A5 (ja)
CS (1) CS207784B2 (ja)
ES (1) ES478539A0 (ja)
FR (1) FR2419729B1 (ja)
GB (1) GB2016271B (ja)
HK (1) HK49283A (ja)
IE (1) IE48269B1 (ja)
IT (1) IT1162282B (ja)
MT (1) MTP843B (ja)
MX (1) MX5996E (ja)
NL (1) NL7901917A (ja)
PH (1) PH16903A (ja)
PT (1) PT69341A (ja)
ZA (1) ZA791103B (ja)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3320583A1 (de) * 1983-06-08 1984-12-13 Dr. Karl Thomae Gmbh, 7950 Biberach Neue galenische zubereitungsformen von oralen antidiabetika und verfahren zu ihrer herstellung
ES2055894T3 (es) * 1989-04-07 1994-09-01 Ciba Geigy Ag Concentrados de sustancias activas pesticidas y su preparacion.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3432593A (en) * 1963-09-18 1969-03-11 Key Pharm Inc Delayed and sustained release type pharmaceutical preparation
JPS5635169B2 (ja) * 1974-02-14 1981-08-15
SE421042B (sv) * 1976-06-29 1981-11-23 Kockums Chem Sett att minska den for en viss biologisk effekt erforderliga mengden biologiskt aktiv substans
JPS53148519A (en) * 1977-05-31 1978-12-25 Sumitomo Chem Co Ltd Preparation of solid medicine containing gefarnate

Also Published As

Publication number Publication date
CS207784B2 (en) 1981-08-31
ES8200632A1 (es) 1981-11-01
FR2419729A1 (fr) 1979-10-12
PH16903A (en) 1984-04-10
JPS54122718A (en) 1979-09-22
FR2419729B1 (fr) 1988-07-08
NL7901917A (nl) 1979-09-18
ES478539A0 (es) 1981-11-01
AR218711A1 (es) 1980-06-30
ZA791103B (en) 1980-03-26
HK49283A (en) 1983-11-11
CH637827A5 (fr) 1983-08-31
MX5996E (es) 1984-09-18
GB2016271B (en) 1982-09-02
IT1162282B (it) 1987-03-25
MTP843B (en) 1980-02-11
GB2016271A (en) 1979-09-26
BE874795A (fr) 1979-07-02
IE790725L (en) 1979-09-14
JPS6026093B2 (ja) 1985-06-21
PT69341A (fr) 1979-04-01
IT7948332A0 (it) 1979-03-13

Similar Documents

Publication Publication Date Title
US4956386A (en) Pharmaceutical compositions and process for their preparation
EP0317878B1 (de) Stabilisierte Arzneistoffe, Verfahren zu ihrer Herstellung sowie stabile Arzneizubereitungen
CA1040532A (en) Process for producing solid bismuth-containing pharmaceutical compositions
JP2740993B2 (ja) 内服用新規医薬製剤
AU658171B2 (en) Orally administerable drugs for the treatment of central dopamine deficiency conditions
US3624209A (en) Composition for treatment of gastro-intestinal disorders
PT71727A (en) Process for preparing a pharmaceutical composition particularly suitable for cancer treatment
IE48879B1 (en) An analgesic effervescent powder and process for its preparation
US4801608A (en) Bismuth containing composition and method for the preparation thereof
JPH11514629A (ja) 安定な甲状腺ホルモン含有薬剤
EP0075992B1 (en) Bismuth containing composition and method for the preparation thereof
JPH0629190B2 (ja) 新規薬学的組成物
US4066787A (en) Stabilized prostaglandin composition and the process for the preparation thereof
IE48269B1 (en) A process for producing gefarnate-containing solid preparations
EP0159777A1 (en) Stabilized 4-carbamoyl-imidazolium-5-olate
JPS6320409B2 (ja)
US4465838A (en) Oxaprozin calcium salt
US2918485A (en) Dihydroxy aluminum salicylates
US5043168A (en) Solid choline magnesium salicylate composition and method of preparing same
JP3547783B2 (ja) 胃炎、胃・十二指腸潰瘍の予防及び治療剤
US2555463A (en) Stabilized sodium pantothenate composition
US4338311A (en) Hydrophilic choline salicylate formulation
KR880002266B1 (ko) 종양 발육 억제 조성물
KR810001315B1 (ko) 게파르나이트 함유 고형제제의 제조방법
US3070503A (en) Pyrilamine resin absorbate with aspirin and/or ascorbic acid

Legal Events

Date Code Title Description
MM4A Patent lapsed